10th Feb 2026 12:02
10 February 2026
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Restatement of Net Asset Value(s)
The Board of International Biotechnology Trust plc (the "Company") announces that, due to an administrative error relating to the non-accrual of the Company's most recent interim dividend, the Company's unaudited cum income net asset value ("NAV") per share has been restated for the following dates, as follows:
Date | Published Cum Income NAV per Share | Revised Cum Income NAV per Share |
29/12/2025 | 1021.50 | 1005.87 |
30/12/2025 | 1016.30 | 1000.69 |
31/12/2025 | 1024.00 | 1008.35 |
02/01/2026 | 1013.20 | 997.59 |
05/01/2026 | 998.07 | 982.44 |
06/01/2026 | 1004.10 | 988.51 |
07/01/2026 | 1035.70 | 1020.10 |
08/01/2026 | 1025.30 | 1009.67 |
09/01/2026 | 1032.20 | 1016.53 |
12/01/2026 | 1010.90 | 995.29 |
13/01/2026 | 1007.40 | 991.72 |
14/01/2026 | 1031.00 | 1015.36 |
15/01/2026 | 1021.10 | 1005.51 |
16/01/2026 | 1013.60 | 997.96 |
19/01/2026 | 1009.70 | 994.04 |
As a result, the Company's service providers have implemented corrective measures and enhanced their procedures.
Enquiries:
Natalia de Sousa
Schroder Investment Management Limited
Tel: 020 7658 6000
Related Shares:
Int.biotech.